![Richard Glickman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Glickman
Président chez
ENGENE THERAPEUTICS INC.
Fortune : 179 366 $ au 31/05/2026
Profil
Richard M.
Glickman was the founder of Aurinia Pharmaceuticals, Inc., founded in 1993, where the title held was Chairman & Chief Executive Officer from 2013 to 2019.
Dr. Glickman was the founder of Aspreva Pharmaceuticals Corp., founded in 2001, where the title held was Chairman & Chief Executive Officer from 2001 to 2006.
Dr. Glickman is also the founder of Probtec Corp.,Nventa Biopharmaceuticals Corp.,Stressgen Biotechnologies Corp.,Ontario Molecular Diagnostics,Aurinia Pharmaceuticals, Inc.,Aurinia Pharma Corp...
Dr. Glickman is Chairman at enGene Therapeutics, Inc. since 2024.
Dr. Glickman is Director at MedGenesis Therapeutix, Inc. Dr. Glickman is Director at enGene, Inc. since 2011.
Dr. Glickman is Independent Director at Eupraxia Pharmaceuticals, Inc. since 2021.
Dr. Glickman is Director at Vida Pharmaceuticals Pvt Ltd. Dr. Glickman is Director at Eurpraxia Pharmaceuticals, Inc. Dr. Glickman is Venture Partner at Lumira Capital Investment Management, Inc. Former positions include Chairman at Vigil Health Solutions, Inc. and LifeSciences British Columbia.
Chairman at ESSA Pharma, Inc. from 2010 to 2025.
Lead Independent Director at Correvio Pharma Corp.
Director at Canadian Genetic Disease Network, Vancouver Aquarium, and viDA Therapeutics, Inc. Member at Innovate BC.
Venture Partner at Kearny Venture Partners.
Education includes undergraduate degree from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2026 | 18 860 ( 0,03 % ) | 133 717 $ | 31/05/2026 | |
ENGENE THERAPEUTICS INC. 0,04 % | 16/06/2026 | 24 675 ( 0,04 % ) | 45 649 $ | 31/05/2026 |
Postes actifs de Richard Glickman
| Sociétés | Poste | Début |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 09/03/2021 |
| ENGENE THERAPEUTICS INC. | Président | 15/05/2024 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | - |
Vida Pharmaceuticals Pvt Ltd. | Directeur/Membre du Conseil | - |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology Provides diagnostic product services | Directeur/Membre du Conseil | - |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Directeur/Membre du Conseil | 23/09/2011 |
Anciens postes connus de Richard Glickman
| Sociétés | Poste | Fin |
|---|---|---|
| ESSA PHARMA INC. | Président | 09/10/2025 |
| AURINIA PHARMACEUTICALS INC. | Directeur Général | 29/04/2019 |
Aurinia Pharma Corp.
 Aurinia Pharma Corp. Drugstore ChainsRetail Trade Operates pharmacies | Directeur Général | 01/01/2019 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Richard Glickman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
MedGenesis Therapeutix, Inc.
MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology Provides diagnostic product services | Health Technology |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
Vigil Health Solutions, Inc.
 Vigil Health Solutions, Inc. Internet Software/ServicesTechnology Services Operates as an online platform for senior living, memory care, assisted living, rehab and skilled nursing | Technology Services |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stressgen Biotechnologies Corp. /Bioreagents Business/
 Stressgen Biotechnologies Corp. /Bioreagents Business/ BiotechnologyHealth Technology Manufactures and develops biological reagents and related anti-bodies | Health Technology |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Develops entrepreneurial talent and supports commercializing technology | Commercial Services |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Canadian Genetic Disease Network | |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners invests in companies located in the United States. The firm focuses on healthcare and healthcare product sector. It participates in early stage transactions. | Finance |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Operates aquarium | Commercial Services |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Ontario Molecular Diagnostics | |
Probtec Corp. | |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Aurinia Pharmaceuticals, Inc. /Old/
 Aurinia Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides related services | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Aurinia Pharma Corp.
Aurinia Pharma Corp. Drugstore ChainsRetail Trade Operates pharmacies | Retail Trade |
Vida Pharmaceuticals Pvt Ltd. | |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Choisissez Zonebourse 
